Narcolepsy In Children And Adolescents
Published on: August 19, 2024
Narcolepsy In Children And Adolescents
Article author photo

David John Green

Article reviewer photo

Asha Waugh

BSc Human Biology, University of Glasgow

Narcolepsy is a chronic neurological condition in which the brain lacks the ability to regulate sleep-wake cycles normally. It is a relatively rare condition, affecting about 1 in 2,000 people globally. The condition can have a dramatic impact on a person’s quality of life, especially if they develop it during childhood or adolescence.1,2 Most people who develop narcolepsy start noticing the issue when they reach adulthood, but in some people this happens much earlier in life, creating unique challenges for diagnosis and management.1

Understanding narcolepsy

When most people hear the word narcolepsy, they usually think about excessive daytime sleepiness and an inability to stay awake. These are certainly the most well-known features of the disorder, but many more issues can develop that are just as troubling. Another major symptom is cataplexy, which is a sudden loss of muscle tone triggered by strong emotions.3,4 Other symptoms include sleep paralysis and hypnagogic hallucinations, which will be explained later.

Experts in this area usually recognize two major types of narcolepsy:1,4

  • Type 1: this type includes cataplexy and is often associated with low levels of hypocretin (orexin), a neurotransmitter that promotes wakefulness
  • Type 2: this type does not include cataplexy and generally has normal hypocretin levels

Causes of narcolepsy

The exact reason why people develop narcolepsy is still unknown, but it’s probably caused by a combination of genetic, environmental, and autoimmune factors.4–6 People with type 1 narcolepsy appear to have a significant lack of hypocretin-producing neurons in the hypothalamus, often attributed to an autoimmune attack. This is where the body mistakes its own cells as threatening and activates systems to target and destroy them.

Some people might be genetically predisposed to narcolepsy. Certain variations in the human leukocyte antigen complex are strongly associated with an increased risk of developing narcolepsy. However, not everyone with this genetic marker will develop the disorder, suggesting that other factors are involved.

Diagnosis

Diagnosing narcolepsy in children and adolescents can be particularly challenging.7,8 The symptoms often overlap with those of deficit hyperactivity disorder, depression, and other sleep disorders. To make matters even more complicated, younger children can often find it difficult to articulate their experiences.

A comprehensive diagnostic evaluation typically includes:9

  • Medical history and symptom assessment: a detailed history of sleep patterns, daytime sleepiness, and any episodes of cataplexy or other symptoms is crucial
  • Sleep diary and questionnaires: Parents may be asked to keep a sleep diary, and children might complete sleep questionnaires to provide additional insight into their sleep habits
  • Polysomnography: an overnight sleep study conducted in a sleep lab to monitor various physiological parameters during sleep, such as brain activity, eye movements, muscle activity, heart rate, and breathing
  • Multiple sleep latency test: this is usually conducted the day after polysomnography to measure how quickly a person falls asleep in a quiet environment during the day and whether they enter rapid eye movement (REM) sleep. A quick onset of sleep and early REM periods can indicate narcolepsy
  • Hypocretin levels: in some cases, cerebrospinal fluid analysis may be performed to measure hypocretin levels, especially if the person is experiencing cataplexy

Symptoms and daily life

Narcolepsy symptoms can significantly impact a child's academic performance, social interactions, and overall quality of life.4,8,10

Key symptoms include:

  • Excessive daytime sleepiness (EDS): persistent sleepiness can lead to difficulty concentrating, memory problems, and frequent naps or unintended sleep episodes during the day8
  • Cataplexy: sudden episodes of muscle weakness that are triggered by strong emotions, such as laughter, excitement, or anger. These episodes can range from slight drooping of the eyelids to complete body collapse3
  • Sleep paralysis: temporary inability to move or speak while falling asleep or waking up, often accompanied by a sense of fear or dread
  • Hypnagogic hallucinations: vivid and often frightening dream-like experiences that happen at the onset of sleep
  • Fragmented nighttime sleep: despite excessive sleepiness during the day, children with narcolepsy often experience disrupted nighttime sleep with frequent awakenings

The impact of these symptoms extends beyond physical health. Children and adolescents with narcolepsy may face social stigma, bullying, and misunderstandings from peers and teachers who may not recognise the seriousness of the disorder. This can lead the individual to feel isolated, anxious or depressed if they are not supported properly. 

Treatment and management

There is no known cure for narcolepsy, but there are a number of treatment strategies that can help manage the symptoms and improve quality of life. A multidisciplinary approach that involves healthcare providers, educators, and family support is often necessary.11

Medication

  • Stimulants: medications like modafinil, armodafinil, and methylphenidate can help reduce EDS
  • Sodium oxybate: effective for both EDS and cataplexy – it improves nighttime sleep quality
  • Antidepressants: certain antidepressants, such as selective serotonin reuptake inhibitors or tricyclic antidepressants can help with cataplexy, sleep paralysis, and hypnagogic hallucinations

Behavioral interventions

  • Scheduled naps: incorporating short, regular naps into the daily routine can help manage daytime sleepiness
  • Sleep hygiene: establishing a consistent sleep schedule, creating a relaxing bedtime routine, and maintaining a sleep-friendly environment can improve overall sleep quality

Education and support

  • School accommodations: developing an individualised education plan (IEP) or 504 plan can provide necessary support in the academic setting, such as allowing for nap breaks, extended test times, or a modified schedule
  • Counseling: psychological support through counseling or therapy can help children and adolescents cope with the emotional and social challenges of living with narcolepsy
  • Support groups: connecting other people who live with narcolepsy can provide a sense of community and understanding.

Research and future directions

Ongoing research is essential to deepen our understanding of narcolepsy and to develop more effective treatments. Here are some of the key areas researchers are focusing on:

Genetic studies 

Scientists are working to identify more genetic markers that might be linked to narcolepsy. By understanding how these genes interact with environmental factors, researchers hope to uncover the underlying causes of the disorder. This knowledge could lead to earlier diagnosis and more personalised treatment options.5

Autoimmune mechanisms

There is growing evidence that narcolepsy may be an autoimmune disorder, where the body's immune system mistakenly attacks its own cells. By studying these autoimmune components, researchers aim to find new ways to prevent or slow down the progression of narcolepsy. This could involve developing treatments that protect the cells in the brain that produce hypocretin.

Hypocretin replacement 

One of the most promising areas of research involves hypocretin replacement therapies. Since people with narcolepsy type 1 often have low levels of hypocretin, a chemical that helps regulate wakefulness, replacing this substance could address the root cause of the disorder. Scientists are exploring various methods to safely and effectively increase hypocretin levels in the brain.9

New medications 

Developing new medications is a major focus for improving the lives of those with narcolepsy. Researchers are working on drugs that are more effective and have fewer side effects than current treatments. These new medications could provide better control over symptoms like excessive daytime sleepiness and cataplexy, leading to a higher quality of life for patients.

By exploring these areas in more detail, researchers hope to advance our ability to diagnose and treat narcolepsy.

Summary

Narcolepsy in children and adolescents is extremely complex and challenging, and can’t be managed properly without a comprehensive and individualised approach to diagnosis and management. Children and adolescents with narcolepsy have significant hurdles to overcome if they are to develop normally and participate in society. However, with appropriate medical treatment, behavioral intervention, and support systems, children with narcolepsy can lead fulfilling and productive lives. Continued research and increased awareness are essential to advancing our understanding of this disorder and improving outcomes for affected individuals. 

References

  1. Barateau, L., Pizza, F., Plazzi, G. & Dauvilliers, Y. Narcolepsy. J Sleep Res 31, e13631 (2022).
  2. Medicine, A. A. of S. International Classification of Sleep Disorders. (American Acad. of Sleep Medicine, Darien, Ill, 2014).
  3. Dauvilliers, Y., Arnulf, I. & Mignot, E. Narcolepsy with cataplexy. Lancet 369, 499–511 (2007).
  4. Bassetti, C. L. A. et al. Narcolepsy - clinical spectrum, aetiopathophysiology, diagnosis and treatment. Nat Rev Neurol 15, 519–539 (2019).
  5. Mignot, E. Genetic and familial aspects of narcolepsy. Neurology 50, S16-22 (1998).
  6. Mahlios, J., De la Herrán-Arita, A. K. & Mignot, E. The autoimmune basis of narcolepsy. Curr Opin Neurobiol 23, 767–773 (2013).
  7. Thorpy, M. J. & Krieger, A. C. Delayed diagnosis of narcolepsy: characterization and impact. Sleep Med 15, 502–507 (2014).
  8. Guilleminault, C. & Brooks, S. N. Excessive daytime sleepiness: a challenge for the practising neurologist. Brain 124, 1482–1491 (2001).
  9. Seigneur, E. & Lecea, L. de. Hypocretin (Orexin) Replacement Therapies. Med Drug Discov 8, 100070 (2020).
  10. Black, J. et al. Medical comorbidity in narcolepsy: findings from the Burden of Narcolepsy Disease (Bond) study. Sleep Med 33, 13–18 (2017).
  11. Maski, K. et al. Treatment of central disorders of hypersomnolence: an American Academy of Sleep Medicine clinical practice guideline. J Clin Sleep Med 17, 1881–1893 (2021).
Share

David John Green

arrow-right